IDYA vs. RXRX
Compare and contrast key facts about IDEAYA Biosciences, Inc. (IDYA) and Recursion Pharmaceuticals, Inc. (RXRX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: IDYA or RXRX.
Performance
IDYA vs. RXRX - Performance Comparison
Returns By Period
In the year-to-date period, IDYA achieves a -24.70% return, which is significantly higher than RXRX's -42.19% return.
IDYA
-24.70%
-9.19%
-28.96%
-15.22%
30.29%
N/A
RXRX
-42.19%
-9.95%
-37.77%
-15.93%
N/A
N/A
Fundamentals
| IDYA | RXRX | |
|---|---|---|
| Market Cap | $2.24B | $1.80B |
| EPS | -$2.30 | -$1.54 |
| Total Revenue (TTM) | $3.92M | $65.18M |
| Gross Profit (TTM) | $720.00K | $1.96M |
| EBITDA (TTM) | -$223.50M | -$366.27M |
Key characteristics
| IDYA | RXRX | |
|---|---|---|
| Sharpe Ratio | -0.33 | -0.19 |
| Sortino Ratio | -0.18 | 0.29 |
| Omega Ratio | 0.98 | 1.03 |
| Calmar Ratio | -0.33 | -0.18 |
| Martin Ratio | -0.76 | -0.37 |
| Ulcer Index | 20.00% | 43.31% |
| Daily Std Dev | 46.07% | 82.18% |
| Max Drawdown | -74.64% | -88.97% |
| Current Drawdown | -43.16% | -86.21% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between IDYA and RXRX is 0.40, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Risk-Adjusted Performance
IDYA vs. RXRX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for IDEAYA Biosciences, Inc. (IDYA) and Recursion Pharmaceuticals, Inc. (RXRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
IDYA vs. RXRX - Dividend Comparison
Neither IDYA nor RXRX has paid dividends to shareholders.
Drawdowns
IDYA vs. RXRX - Drawdown Comparison
The maximum IDYA drawdown since its inception was -74.64%, smaller than the maximum RXRX drawdown of -88.97%. Use the drawdown chart below to compare losses from any high point for IDYA and RXRX. For additional features, visit the drawdowns tool.
Volatility
IDYA vs. RXRX - Volatility Comparison
The current volatility for IDEAYA Biosciences, Inc. (IDYA) is 15.67%, while Recursion Pharmaceuticals, Inc. (RXRX) has a volatility of 21.24%. This indicates that IDYA experiences smaller price fluctuations and is considered to be less risky than RXRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
IDYA vs. RXRX - Financials Comparison
This section allows you to compare key financial metrics between IDEAYA Biosciences, Inc. and Recursion Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities